{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:20:20Z","timestamp":1790958020640,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS122766"],"award-info":[{"award-number":["R01NS122766"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["K00NS125830"],"award-info":[{"award-number":["K00NS125830"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG089267"],"award-info":[{"award-number":["R21AG089267"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U01AG058589"],"award-info":[{"award-number":["U01AG058589"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68808-3","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T04:46:17Z","timestamp":1770007577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A common 19\u2009bp APOE enhancer deletion is protective against Alzheimer\u2019s disease in African Americans"],"prefix":"10.1038","volume":"17","author":[{"given":"Julianna N.","family":"Brutman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Busald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5866-0400","authenticated-orcid":false,"given":"Evangelos","family":"Nizamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8553-210X","authenticated-orcid":false,"given":"Eli J.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6984-2159","authenticated-orcid":false,"given":"Eugene","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nzinga E.","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6975-7878","authenticated-orcid":false,"given":"Sana","family":"Chintamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvis","family":"Sulovari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel N.","family":"Smukowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidian","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Peikon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3164-9665","authenticated-orcid":false,"given":"Suman","family":"Jayadev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Logsdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2725-6669","authenticated-orcid":false,"given":"Ellen M.","family":"Wijsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0633-0305","authenticated-orcid":false,"given":"Elizabeth E.","family":"Blue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8840-6969","authenticated-orcid":false,"given":"Paul N.","family":"Valdmanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"68808_CR1","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 20, 3708\u20133821 (2024).","DOI":"10.1002\/alz.13809"},{"key":"68808_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261, 921\u2013923 (1993).","journal-title":"Science"},{"key":"68808_CR3","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/mp.2011.52","volume":"16","author":"E Genin","year":"2011","unstructured":"Genin, E. et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol. Psychiatry 16, 903\u2013907 (2011).","journal-title":"Mol. Psychiatry"},{"key":"68808_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat. Genet. 54, 412\u2013436 (2022).","journal-title":"Nat. Genet."},{"key":"68808_CR5","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat. Genet. 45, 1452\u20131458 (2013).","journal-title":"Nat. Genet."},{"key":"68808_CR6","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1073\/pnas.70.7.2015","volume":"70","author":"RJ Havel","year":"1973","unstructured":"Havel, R. J. & Kane, J. P. Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins. Proc. Natl. Acad. Sci. USA 70, 2015\u20132019 (1973).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68808_CR7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0022-2275(20)38094-9","volume":"23","author":"VI Zannis","year":"1982","unstructured":"Zannis, V. I. et al. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J. Lipid Res. 23, 911\u2013914 (1982).","journal-title":"J. Lipid Res."},{"key":"68808_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ng1197-263","volume":"17","author":"KR Bales","year":"1997","unstructured":"Bales, K. R. et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet. 17, 263\u2013264 (1997).","journal-title":"Nat. Genet."},{"key":"68808_CR9","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter, W. J. et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977\u20131981 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68808_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C. H. et al. Lecanemab in Early Alzheimer\u2019s Disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"68808_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jalz.2009.04.1234","volume":"5","author":"GG Potter","year":"2009","unstructured":"Potter, G. G. et al. Cognitive performance and informant reports in the diagnosis of cognitive impairment and dementia in African Americans and whites. Alzheimers Dement 5, 445\u2013453 (2009).","journal-title":"Alzheimers Dement"},{"key":"68808_CR12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1377\/hlthaff.2013.1353","volume":"33","author":"LL Barnes","year":"2014","unstructured":"Barnes, L. L. & Bennett, D. A. Alzheimer\u2019s disease in African Americans: risk factors and challenges for the future. Health Aff. (Millwood) 33, 580\u2013586 (2014).","journal-title":"Health Aff. (Millwood)"},{"key":"68808_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jalz.2015.12.007","volume":"12","author":"ER Mayeda","year":"2016","unstructured":"Mayeda, E. R., Glymour, M. M., Quesenberry, C. P. & Whitmer, R. A. Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimers Dement 12, 216\u2013224 (2016).","journal-title":"Alzheimers Dement"},{"key":"68808_CR14","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/jama.2013.2973","volume":"309","author":"C Reitz","year":"2013","unstructured":"Reitz, C. et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E 4,and the risk of late-onset Alzheimer disease in African Americans. JAMA 309, 1483\u20131492 (2013).","journal-title":"JAMA"},{"key":"68808_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/jamaneurol.2020.3536","volume":"78","author":"BW Kunkle","year":"2021","unstructured":"Kunkle, B. W. et al. Novel Alzheimer disease risk loci and pathways in African American individuals using the African genome resources panel: a meta-analysis. JAMA Neurol. 78, 102\u2013113 (2021).","journal-title":"JAMA Neurol."},{"key":"68808_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1046\/j.1469-1809.1999.6340301.x","volume":"63","author":"Corbo","year":"1999","unstructured":"Corbo & Scacchi, R. M. R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a \u2018thrifty\u2019 allele? Ann. Hum. Genet 63, 301\u2013310 (1999).","journal-title":"Ann. Hum. Genet"},{"key":"68808_CR17","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.jalz.2019.07.016","volume":"15","author":"EE Blue","year":"2019","unstructured":"Blue, E. E., Horimoto, A., Mukherjee, S., Wijsman, E. M. & Thornton, T. A. Local ancestry at APOE modifies Alzheimer\u2019s disease risk in Caribbean Hispanics. Alzheimers Dement 15, 1524\u20131532 (2019).","journal-title":"Alzheimers Dement"},{"key":"68808_CR18","doi-asserted-by":"publisher","first-page":"e1007791","DOI":"10.1371\/journal.pgen.1007791","volume":"14","author":"F Rajabli","year":"2018","unstructured":"Rajabli, F. et al. Ancestral origin of ApoE epsilon4 Alzheimer disease risk in Puerto Rican and African American populations. PLoS Genet 14, e1007791 (2018).","journal-title":"PLoS Genet"},{"key":"68808_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep04383","volume":"4","author":"M Liu","year":"2014","unstructured":"Liu, M., Bian, C., Zhang, J. & Wen, F. Apolipoprotein E gene polymorphism and Alzheimer\u2019s disease in Chinese population: a meta-analysis. Sci. Rep. 4, 4383 (2014).","journal-title":"Sci. Rep."},{"key":"68808_CR20","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 1349\u20131356 (1997).","journal-title":"JAMA"},{"key":"68808_CR21","doi-asserted-by":"crossref","unstructured":"Choi, K. Y. et al. APOE Promoter Polymorphism-219T\/G is an Effect Modifier of the Influence of APOE epsilon4 on Alzheimer\u2019s Disease Risk in a Multiracial Sample. J Clin Med 8 (2019).","DOI":"10.3390\/jcm8081236"},{"key":"68808_CR22","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/jama.2023.0268","volume":"329","author":"Y Le Guen","year":"2023","unstructured":"Le Guen, Y. et al. Association of African Ancestry-Specific APOE Missense Variant R145C With Risk of Alzheimer Disease. JAMA 329, 551\u2013560 (2023).","journal-title":"JAMA"},{"key":"68808_CR23","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/jamaneurol.2022.1166","volume":"79","author":"Y Le Guen","year":"2022","unstructured":"Le Guen, Y. et al. Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease. JAMA Neurol. 79, 652\u2013663 (2022).","journal-title":"JAMA Neurol."},{"key":"68808_CR24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41586-023-05896-x","volume":"617","author":"WW Liao","year":"2023","unstructured":"Liao, W. W. et al. A draft human pangenome reference. Nature 617, 312\u2013324 (2023).","journal-title":"Nature"},{"key":"68808_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"C Genomes Project","year":"2015","unstructured":"Genomes Project, C. et al. A global reference for human genetic variation. Nature 526, 68\u201374 (2015).","journal-title":"Nature"},{"key":"68808_CR26","unstructured":"Ebert, P. et al. Haplotype-resolved diverse human genomes and integrated analysis of structural variation. Science (2021)."},{"key":"68808_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nn.3318","volume":"16","author":"K Kierdorf","year":"2013","unstructured":"Kierdorf, K. et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 16, 273\u2013280 (2013).","journal-title":"Nat. Neurosci."},{"key":"68808_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s41232-022-00201-1","volume":"42","author":"I Sonn","year":"2022","unstructured":"Sonn, I. et al. Single transcription factor efficiently leads human induced pluripotent stem cells to functional microglia. Inflamm. Regen. 42, 20 (2022).","journal-title":"Inflamm. Regen."},{"key":"68808_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat. Genet 51, 414\u2013430 (2019).","journal-title":"Nat. Genet"},{"key":"68808_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0150-6","volume":"8","author":"RE Marioni","year":"2018","unstructured":"Marioni, R. E. et al. GWAS on family history of Alzheimer\u2019s disease. Transl. Psychiatry 8, 99 (2018).","journal-title":"Transl. Psychiatry"},{"key":"68808_CR31","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/nn.4587","volume":"20","author":"KL Huang","year":"2017","unstructured":"Huang, K. L. et al. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer\u2019s disease. Nat. Neurosci. 20, 1052\u20131061 (2017).","journal-title":"Nat. Neurosci."},{"key":"68808_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13960-2","volume":"11","author":"J Minderjahn","year":"2020","unstructured":"Minderjahn, J. et al. Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1. Nat. Commun. 11, 402 (2020).","journal-title":"Nat. Commun."},{"key":"68808_CR33","volume":"4","author":"A Horimoto","year":"2023","unstructured":"Horimoto, A. et al. Admixture mapping implicates 13q33.3 as ancestry-of-origin locus for Alzheimer disease in Hispanic and Latino populations. HGG Adv. 4, 100207 (2023).","journal-title":"HGG Adv."},{"key":"68808_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41586-023-06957-x","volume":"627","author":"All of Us Research Program Genomics, I","year":"2024","unstructured":"All of Us Research Program Genomics, I Genomic data in the All of Us Research Program. Nature 627, 340\u2013346 (2024).","journal-title":"Nature"},{"key":"68808_CR35","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1161\/01.ATV.20.7.1800","volume":"20","author":"F de Beer","year":"2000","unstructured":"de Beer, F. et al. Apolipoprotein E2 (Lys146->Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low density lipoproteins-triglycerides. Arterioscler Thromb. Vasc. Biol. 20, 1800\u20131806 (2000).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"68808_CR36","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1053\/jhep.2002.34745","volume":"36","author":"MA Wozniak","year":"2002","unstructured":"Wozniak, M. A. et al. Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus. Hepatology 36, 456\u2013463 (2002).","journal-title":"Hepatology"},{"key":"68808_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/science.adh7699","volume":"380","author":"JA Morris","year":"2023","unstructured":"Morris, J. A. et al. Discovery of target genes and pathways at GWAS loci by pooled single-cell CRISPR screens. Science 380, eadh7699 (2023).","journal-title":"Science"},{"key":"68808_CR38","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"G Consortium","year":"2020","unstructured":"Consortium, G. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318\u20131330 (2020).","journal-title":"Science"},{"key":"68808_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105217","volume":"148","author":"AA Pimenova","year":"2021","unstructured":"Pimenova, A. A. et al. Alzheimer\u2019s-associated PU.1 expression levels regulate microglial inflammatory response. Neurobiol. Dis. 148, 105217 (2021).","journal-title":"Neurobiol. Dis."},{"key":"68808_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48484-x","volume":"15","author":"B Kim","year":"2024","unstructured":"Kim, B. et al. Effects of SPI1-mediated transcriptome remodeling on Alzheimer\u2019s disease-related phenotypes in mouse models of Abeta amyloidosis. Nat. Commun. 15, 3996 (2024).","journal-title":"Nat. Commun."},{"key":"68808_CR41","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3233\/JAD-2010-100576","volume":"23","author":"JF Berbee","year":"2011","unstructured":"Berbee, J. F. et al. Apolipoprotein CI knock-out mice display impaired memory functions. J. Alzheimers Dis. 23, 737\u2013747 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"68808_CR42","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1194\/jlr.M700518-JLR200","volume":"49","author":"K Abildayeva","year":"2008","unstructured":"Abildayeva, K. et al. Human apolipoprotein C-I expression in mice impairs learning and memory functions. J. Lipid Res 49, 856\u2013869 (2008).","journal-title":"J. Lipid Res"},{"key":"68808_CR43","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nrg3336","volume":"13","author":"M O\u2019Bleness","year":"2012","unstructured":"O\u2019Bleness, M., Searles, V. B., Varki, A., Gagneux, P. & Sikela, J. M. Evolution of genetic and genomic features unique to the human lineage. Nat. Rev. Genet 13, 853\u2013866 (2012).","journal-title":"Nat. Rev. Genet"},{"key":"68808_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.61.8.3","volume":"61","author":"MA Margeta","year":"2020","unstructured":"Margeta, M. A. et al. Association of APOE With Primary Open-Angle Glaucoma Suggests a Protective Effect for APOE epsilon4. Invest Ophthalmol. Vis. Sci. 61, 3 (2020).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"68808_CR45","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.immuni.2022.07.014","volume":"55","author":"MA Margeta","year":"2022","unstructured":"Margeta, M. A. et al. Apolipoprotein E4 impairs the response of neurodegenerative retinal microglia and prevents neuronal loss in glaucoma. Immunity 55, 1627\u20131644 e7 (2022).","journal-title":"Immunity"},{"key":"68808_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.stem.2020.12.018","volume":"28","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response. Cell Stem Cell 28, 331\u2013342 e5 (2021).","journal-title":"Cell Stem Cell"},{"key":"68808_CR47","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41586-022-05344-2","volume":"611","author":"BN Ostendorf","year":"2022","unstructured":"Ostendorf, B. N. et al. Common human genetic variants of APOE impact murine COVID-19 mortality. Nature 611, 346\u2013351 (2022).","journal-title":"Nature"},{"key":"68808_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade9797","volume":"9","author":"BC Trumble","year":"2023","unstructured":"Trumble, B. C. et al. Apolipoprotein-epsilon4 is associated with higher fecundity in a natural fertility population. Sci. Adv. 9, eade9797 (2023).","journal-title":"Sci. Adv."},{"key":"68808_CR49","doi-asserted-by":"publisher","first-page":"e1009977","DOI":"10.1371\/journal.pgen.1009977","volume":"18","author":"F Rajabli","year":"2022","unstructured":"Rajabli, F. et al. A locus at 19q13.31 significantly reduces the ApoE epsilon4 risk for Alzheimer\u2019s Disease in African Ancestry. PLoS Genet 18, e1009977 (2022).","journal-title":"PLoS Genet"},{"key":"68808_CR50","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1523\/JNEUROSCI.21-03-00812.2001","volume":"21","author":"S Grehan","year":"2001","unstructured":"Grehan, S., Tse, E. & Taylor, J. M. Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain. J. Neurosci. 21, 812\u2013822 (2001).","journal-title":"J. Neurosci."},{"key":"68808_CR51","doi-asserted-by":"publisher","first-page":"31567","DOI":"10.1074\/jbc.M005468200","volume":"275","author":"SJ Shih","year":"2000","unstructured":"Shih, S. J. et al. Duplicated downstream enhancers control expression of the human apolipoprotein E gene in macrophages and adipose tissue. J. Biol. Chem. 275, 31567\u201331572 (2000).","journal-title":"J. Biol. Chem."},{"key":"68808_CR52","doi-asserted-by":"crossref","unstructured":"Nuytemans, K. et al. Identifying differential regulatory control of APOE varepsilon4 on African versus European haplotypes as potential therapeutic targets. Alzheimers Dement (2022).","DOI":"10.1002\/alz.12534"},{"key":"68808_CR53","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41420-025-02600-y","volume":"11","author":"Y Chen","year":"2025","unstructured":"Chen, Y. et al. The multifaceted roles of apolipoprotein E4 in Alzheimer\u2019s disease pathology and potential therapeutic strategies. Cell Death Discov. 11, 312 (2025).","journal-title":"Cell Death Discov."},{"key":"68808_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111200","volume":"40","author":"L Arnaud","year":"2022","unstructured":"Arnaud, L. et al. APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-kappaB activation. Cell Rep. 40, 111200 (2022).","journal-title":"Cell Rep."},{"key":"68808_CR55","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/alz.12287","volume":"17","author":"AJ Griswold","year":"2021","unstructured":"Griswold, A. J. et al. Increased APOE epsilon4 expression is associated with the difference in Alzheimer\u2019s disease risk from diverse ancestral backgrounds. Alzheimers Dement 17, 1179\u20131188 (2021).","journal-title":"Alzheimers Dement"},{"key":"68808_CR56","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet 51, 584\u2013591 (2019).","journal-title":"Nat. Genet"},{"key":"68808_CR57","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1194\/jlr.M076232","volume":"58","author":"S Mack","year":"2017","unstructured":"Mack, S. et al. A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms. J. Lipid Res 58, 1834\u20131844 (2017).","journal-title":"J. Lipid Res"},{"key":"68808_CR58","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s42003-024-06742-0","volume":"7","author":"M Fu","year":"2024","unstructured":"Fu, M. et al. Improving genetic risk modeling of dementia from real-world data in underrepresented populations. Commun. Biol. 7, 1049 (2024).","journal-title":"Commun. Biol."},{"key":"68808_CR59","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/alz.12295","volume":"17","author":"KD Deters","year":"2021","unstructured":"Deters, K. D. et al. TOMM40-APOE haplotypes are associated with cognitive decline in non-demented Blacks. Alzheimers Dement 17, 1287\u20131296 (2021).","journal-title":"Alzheimers Dement"},{"key":"68808_CR60","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jalz.2012.06.009","volume":"9","author":"G Li","year":"2013","unstructured":"Li, G. et al. TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE epsilon3\/epsilon3. Alzheimers Dement 9, 554\u2013561 (2013).","journal-title":"Alzheimers Dement"},{"key":"68808_CR61","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1086\/303070","volume":"67","author":"SM Fullerton","year":"2000","unstructured":"Fullerton, S. M. et al. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am. J. Hum. Genet 67, 881\u2013900 (2000).","journal-title":"Am. J. Hum. Genet"},{"key":"68808_CR62","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s42003-021-01681-6","volume":"4","author":"HC Yang","year":"2021","unstructured":"Yang, H. C., Chen, C. W., Lin, Y. T. & Chu, S. K. Genetic ancestry plays a central role in population pharmacogenomics. Commun. Biol. 4, 171 (2021).","journal-title":"Commun. Biol."},{"key":"68808_CR63","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1093\/bioinformatics\/btu197","volume":"30","author":"RJ Carroll","year":"2014","unstructured":"Carroll, R. J., Bastarache, L. & Denny, J. C. R. PheWAS: data analysis and plotting tools for phenome-wide association studies in the R environment. Bioinformatics 30, 2375\u20132376 (2014).","journal-title":"Bioinformatics"},{"key":"68808_CR64","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/glia.23988","volume":"69","author":"MS Aloi","year":"2021","unstructured":"Aloi, M. S. et al. The pro-inflammatory microRNA miR-155 influences fibrillar beta-Amyloid(1)(-42) catabolism by microglia. Glia 69, 1736\u20131748 (2021).","journal-title":"Glia"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68808-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68808-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68808-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T13:02:23Z","timestamp":1772715743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68808-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68808"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68808-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.L., I.P., S.C., and A.S. are employees of Cajal Neuroscience. All other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2237"}}